Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Preferred Stock Liabilities (2019 - 2020)

Biodesix (BDSX) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $194.0 million as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Preferred Stock Liabilities changed 0.0% year-over-year to $194.0 million, compared with a TTM value of $194.0 million through Sep 2020, changed 0.0%, and an annual FY2019 reading of $194.0 million, changed N/A over the prior year.
  • Preferred Stock Liabilities was $194.0 million for Q3 2020 at Biodesix, roughly flat from $194.0 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $194.0 million in Q3 2019 and bottomed at $194.0 million in Q3 2019.